Cellular

All the way from regenerative research to commercialisation

We speak to the director of the Wake Forest Institute of Regenerative Medicine – a research organisation with a clear focus on commercialisation. Just on...

$85m funding for epigenetic platform technology

Omega Therapeutics secures $85m to carry out clinical trials into epigenetic treatments for five key disease areas – and potentially for Covid-19.  While you might...

Study of twins reveals longitudinal DNA methylation information

A decade-long study has made interesting contributions to the study of the stability of DNA methylation. A study of epigenetic changes in identical twins by...

Self-eating stem cells could unlock regenerative therapies

New discovery could hold the key to regenerative therapies and Longevity. The self-eating ability of cells could uncover new regenerative therapies as a team of...

Hyperbaric oxygen could improve cognitive ability

The hyperbaric oxygen market is growing rapidly as scientists discover more uses in preventing cognitive decline. An innovative form of hyperbaric oxygen therapy (HBOT)...

Mouse model study reveals sight loss therapy hope

Stem cell retinal transplants show promise in the treatment of sight loss.  Sight is the sense that people fear losing most. While there is a...

Skin rejuvenation from novel nano-fat graft technique

New skin rejuvenation technique harnesses the power of Stromal Vascular Fraction stem cells to bring new life to aging skin. Stromal Vascular Fraction is harvested...

New CRISPR-free gene-editing tool exploits bacterial warfare

New tool uses an interbacterial toxin to achieve precise mitochondrial gene editing without CRISPR side-effects. Mitochondria – often called the "powerhouse" of the cell –...

Longevity investment: Apollo aims for the moon

Co-founder of Longevity-focused investment firm shows you can target aging AND appeal to biotech investors. Founded in 2016, Berlin and Boston-based Apollo already boasts an...

Outlived by our organs: different aging rates in the body

Not only is our biological age different from our chronological age, but it varies from organ to organ. Understanding why and how could be...

Breakthrough in understanding protein synthesis and aging

From biomarkers of aging to ribosome distribution, protein synthesis and aging are linked: a new paper reveals how. Making proteins is an enormous part of...

Off-patent protein could be a key to Longevity

Could off-patent humanin actually have a bigger part to play in Longevity and healthy aging? They say that good things come in small packages and a...

Bridging the gap: artificial to biological neuron interfacing

Is non-binary the way forward for BCI (brain computer interfacing)? Chemical computing could be a powerful tool in combating aging. Dopamine is known for playing...

Study shows that diluting blood plasma ‘resets’ aging

Researchers at the University of Berkeley have discovered a way to dilute older blood plasma to slow down aging. A new study from a team...

Re-engineered immune cells are the life and soul of the CAR T

Chimeric cells prove effective senolytic agents in targeting aging. CAR T cells are being deployed against diseases caused by senescence with the hope that they...

Commercial boost for AgeX and pluripotent stem cells

AgeX and Pluristyx announce manufacturing, marketing and distribution agreement. AgeX Therapeutics and Seattle-based Pluristyx today announced they have entered into a manufacturing, marketing and distribution...

Protein’s ability to slow cell growth is Longevity boost

UCL, UEL and Essex University collaboration has discovered that the protein Gaf1 plays a key role in determining the lifespan of cells. A research team...

‘Internet of the body’ device to regulate genes externally

Bioelectric remote control of cell signalling drives synthetic biology progress: tests trigger bioengineered cells to release insulin. A team at the Department of Biosystems Science and...

Link between cellular senescence and plaque formation found

Study identifies CD9 as a novel target to prevent senescence and treat vascular aging. CD9 is a protein expressed on the surface of various cell types,...

eGenesis’ xenotransplantation trials move closer to in-human

eGenesis' groundbreaking xenotransplantation work with Massachusetts General Hospital to be expanded through additional collaboration. eGenesis has announced it is expanding its research collaboration with the...

Latest articles

Rejuvenation Roadmap charts life extension progress

We take a trip down Lifespan.io's Rejuvenation Roadmap – and it's a journey towards Longevity progress. Lifespan.io is a US-based non-profit organisation that seeks to...

Longevity therapies delivered through skin is a topical issue

Non-invasive therapy that comes in a bottle could be the Longevity crème de la crème. Therapeutic substances like arnica, turmeric and witch hazel have been...

Evidence for tenth hallmark of aging increases with new paper

Is ten the new nine? Additional research adds weight to the argument that extracellular matrix stiffening should be considered the tenth hallmark of aging. Since...

Help us help you: Longevity biotech survey

A new survey on translational processes and hurdles to clinical trials in Longevity biotech. We're working with two MDs: Oliver Zolman and Jian Fransen, on...